
Publication|Articles|November 10, 2011
Supplement: Oncology November 2011 Short
The goal of this supplement is to present a comprehensive overview of the major current and emerging treatment options for patients with relapsed and/or refractory multiple myeloma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
2
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
3
Understanding The Training, Credentialing Landscapes for End-of-Life Doulas
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5

























































